MedTrace Logo

Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer

NCT00827333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 372

Last updated 2016-08-02

No results posted yet for this study

Summary

RATIONALE: Palliative care teaching sessions may be more effective than standard care in improving caregiver burden, caregiver skills preparedness, quality of life, and distress in family caregivers of patients with non-small cell lung cancer.

PURPOSE: This clinical trial is studying the effects of palliative care teaching sessions in family caregivers of patients with non-small cell lung cancer.

Conditions

Interventions

OTHER

educational intervention

Family Caregiver Palliative Care Intervention at weeks 7, 8, 10, and 12 post study enrollment

OTHER

questionnaire administration

Occurs at baseline, 7 weeks, 12 weeks, 18 weeks and 24 weeks post enrollment

PROCEDURE

end-of-life treatment/management

Occurs at baseline, 7 weeks, 12 weeks, 18 weeks and 24 weeks post enrollment

PROCEDURE

psychosocial assessment and care

Occurs at baseline, 7 weeks, 12 weeks, 18 weeks and 24 weeks post enrollment

PROCEDURE

quality-of-life assessment

Occurs at baseline, 7 weeks, 12 weeks, 18 weeks and 24 weeks post enrollment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Betty Ferrell, PhD · City of Hope Comprehensive Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00827333 on ClinicalTrials.gov